Ausgabe 4/2012
Including PIH Articles on Epigenetics of Hematopoiesis and hHematopoietic Malignancies
Inhalt (20 Artikel)
Primary intraocular large B cell lymphoma with plasmacytic differentiation
Tohru Inaba, Kenji Nagata, Kazuichi Maruyama
Acquired ichthyosis as a presenting finding of Hodgkin’s lymphoma
Timur Selcuk Akpinar, Abdullah Ozkok, Oguz Kagan Bakkaloglu, Bulent Saka
Guest editorial: Epigenetics of hematopoiesis and hematological malignancies
Atsushi Iwama
Epigenetic alterations in hematopoietic malignancies
Young Rock Chung, Emma Schatoff, Omar Abdel-Wahab
Disordered epigenetic regulation in MLL-related leukemia
Yue Zhang, Aili Chen, Xiao-Mei Yan, Gang Huang
Clonal expansion of Epstein–Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions
Taizo Wada, Akiko Toga, Yasuhisa Sakakibara, Tomoko Toma, Minoru Hasegawa, Kazuhiko Takehara, Tomonari Shigemura, Kazunaga Agematsu, Akihiro Yachie
Polymorphisms in XPC provide prognostic information in acute myeloid leukemia
Peipei Xu, Baoan Chen, Jifeng Feng, Lu Cheng, Guohua Xia, Yufeng Li, Jun Qian, Jiahua Ding, Zuhong Lu
Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms
Nodoka Sekiguchi, Naoko Asano, Toshiro Ito, Kayoko Momose, Masanobu Momose, Fumihiro Ishida
High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group
Akira Shimada, Tomohiko Taki, Daisuke Koga, Ken Tabuchi, Akio Tawa, Ryoji Hanada, Masahiro Tsuchida, Keizo Horibe, Ichiro Tsukimoto, Souichi Adachi, Seiji Kojima, Yasuhide Hayashi
Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma: a feasibility study in Japanese population
Tomoki Ueda, Rioko Iino, Kenji Yokoyama, Shinichiro Okamoto, Keiko Asakura, Yuiko Tsukada, Jo Ishizawa, Eri Matsuki, Yasuo Ikeda, Yutaka Hattori
Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study
Yoshikazu Ito, Atsushi Wakita, Satoru Takada, Masahiro Mihara, Moritaka Gotoh, Kazuma Ohyashiki, Shigeki Ohtake, Shuichi Miyawaki, Kazunori Ohnishi, Tomoki Naoe
Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis
Yuhei Kamada, Mamiko Sakata-Yanagimoto, Masashi Sanada, Aiko Sato-Otsubo, Terukazu Enami, Kazumi Suzukawa, Naoki Kurita, Hidekazu Nishikii, Yasuhisa Yokoyama, Yasushi Okoshi, Yuichi Hasegawa, Seishi Ogawa, Shigeru Chiba
Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy
Hiroaki Tanaka, Shinichiro Hashimoto, Yasumasa Sugita, Shio Sakai, Yusuke Takeda, Daijiro Abe, Toshiyuki Takagi, Chiaki Nakaseko
Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports
Futoshi Iioka, Daiki Shimomura, Toru Ishii, Yoshitomo Maesako, Kazuhiro Ohgoe, Fumihiko Nakamura, Shuji Matsuo, Hitoshi Ohno
A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis
Nay Min Tun, Zaw Min Bo, Meena Ahluwalia, Elizabeth Guevara, Gina M. Villani
Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy
Akinao Okamoto, Akihiro Abe, Masataka Okamoto, Tsukane Kobayashi, Tomohiko Terazawa, Yoko Inaguma, Masutaka Tokuda, Masamitsu Yanada, Satoko Morishima, Tadaharu Kanie, Yukiya Yamamoto, Motohiro Tsuzuki, Yoshiki Akatsuka, Shuichi Mizuta, Tetsushi Yoshikawa, Nobuhiko Emi
Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon
Zaher K. Otrock, Rami A. Mahfouz, Zahera Fahed, Fadi S. Farhat, Azzam Ziade, Fadi Nasr, Nader Kassem, Miguel R. Abboud
Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma
Tomohiko Kamimura, Toshihiro Miyamoto, Shuichiro Takashima, Noriko Yokota, Yong Chong, Yoshikiyo Ito, Koichi Akashi